A Rapid Review of the Asymptomatic Proportion of PCR-Confirmed SARS-CoV-2 Infections in Community Settings

Background: Up to 80% of active SARS-CoV-2 infections are proposed to be asymptomatic based on cross-sectional studies. However, accurate estimates of the asymptomatic proportion require systematic detection and follow-up to differentiate between truly asymptomatic and pre-symptomatic cases. We conducted a rapid review and meta-analysis of current evidence regarding the asymptomatic proportion of PCR-confirmed SARS-CoV-2 infections based on methodologically-appropriate studies in community settings. Methods: We searched Medline and EMBASE for peer-reviewed articles, and BioRxiv and MedRxiv for pre-prints published prior to 05/05/2020. We included studies based in community settings that involved systematic PCR testing on participants and follow-up symptom monitoring regardless of symptom status. We extracted data on study characteristics, frequencies of PCR-confirmed infections by symptom status, and (if available) cycle threshold values and/or duration of viral shedding by symptom status. We computed estimates of the asymptomatic proportion and 95% confidence intervals for each study and overall using random effect meta-analysis. Findings: We screened 270 studies and included 6. The pooled estimate for the asymptomatic proportion of SARS-CoV-2 infections was 11% (95% CI 4%-18%). Estimates of baseline viral load appeared to be similar for asymptomatic and symptomatic cases based on available data in three studies, though detailed reporting of cycle threshold values and natural history of viral shedding by symptom status was limited. Interpretation: The asymptomatic proportion of SARS-CoV-2 infections is relatively low when estimated from methodologically-appropriate studies. Further investigation into the degree and duration of infectiousness for asymptomatic infections is warranted. Funding: Medical Research Council

[1]  R. Myers,et al.  Investigation of SARS-CoV-2 outbreaks in six care homes in London, April 2020 , 2020, EClinicalMedicine.

[2]  E. White,et al.  Whole Care Home Testing for Covid-19 in a Local Authority Area in the United Kingdom , 2020, medRxiv.

[3]  Dong Zhao,et al.  Asymptomatic infection by SARS-CoV-2 in healthcare workers: A study in a large teaching hospital in Wuhan, China , 2020, International Journal of Infectious Diseases.

[4]  J. Tate,et al.  A prospective cohort study in non-hospitalized household contacts with SARS-CoV-2 infection: symptom profiles and symptom change over time , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  Liqing Cheng,et al.  Epidemiological, comorbidity factors with severity and prognosis of COVID-19: a systematic review and meta-analysis , 2020, Aging.

[6]  Graham W. Taylor,et al.  Community prevalence of SARS-CoV-2 virus in England during May 2020: REACT study , 2020, medRxiv.

[7]  Liyan Wen,et al.  Kinetics of viral load and antibody response in relation to COVID-19 severity. , 2020, The Journal of clinical investigation.

[8]  D. Consonni,et al.  Characteristics of 1573 healthcare workers who underwent nasopharyngeal swab testing for SARS-CoV-2 in Milan, Lombardy, Italy , 2020, Clinical Microbiology and Infection.

[9]  E. Crawford,et al.  SARS-CoV-2 Community Transmission During Shelter-in-Place in San Francisco , 2020, medRxiv.

[10]  D. Burdsall,et al.  Asymptomatic SARS-CoV-2 Infection and COVID-19 Mortality During an Outbreak Investigation in a Skilled Nursing Facility , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  Ming-hui Li,et al.  Epidemiological features and viral shedding in children with SARS‐CoV‐2 infection , 2020, Journal of medical virology.

[12]  Satoshi Mimura,et al.  Clinical characteristics of COVID-19 in 104 people with SARS-CoV-2 infection on the Diamond Princess cruise ship: a retrospective analysis , 2020, The Lancet Infectious Diseases.

[13]  D. O’Neill,et al.  Asymptomatic carriage rates and case-fatality of SARS-CoV-2 infection in residents and staff in Irish nursing homes , 2020, medRxiv.

[14]  K. To,et al.  SARS-CoV-2 shedding and seroconversion among passengers quarantined after disembarking a cruise ship: a case series , 2020, The Lancet Infectious Diseases.

[15]  P. Freemont,et al.  SARS-CoV-2 infection, clinical features and outcome of COVID-19 in United Kingdom nursing homes , 2020, Journal of Infection.

[16]  Yalan Qin,et al.  Characterization of an asymptomatic cohort of SARS-COV-2 infected individuals outside of Wuhan, China. , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  Ying-jian Liang,et al.  Household Transmission of SARS-CoV-2, Zhuhai, China, 2020 , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  David A. Drew,et al.  Real-time tracking of self-reported symptoms to predict potential COVID-19 , 2020, Nature Medicine.

[19]  Justin Wong,et al.  Analysis of SARS-CoV-2 transmission in different settings, among cases and close contacts from the Tablighi cluster in Brunei Darussalam , 2020 .

[20]  John T Brooks,et al.  Evidence Supporting Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 While Presymptomatic or Asymptomatic , 2020, Emerging infectious diseases.

[21]  R. Geskus,et al.  The natural history and transmission potential of asymptomatic SARS-CoV-2 infection , 2020, medRxiv.

[22]  D. Raoult,et al.  Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards , 2020, European Journal of Clinical Microbiology & Infectious Diseases.

[23]  Anne Kimball,et al.  Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility , 2020, The New England journal of medicine.

[24]  D. Havlir,et al.  Asymptomatic Transmission, the Achilles’ Heel of Current Strategies to Control Covid-19 , 2020, The New England journal of medicine.

[25]  Young Joon Park,et al.  Coronavirus Disease Outbreak in Call Center, South Korea , 2020, Emerging infectious diseases.

[26]  C. Hopkins,et al.  Alterations in Smell or Taste in Mildly Symptomatic Outpatients With SARS-CoV-2 Infection. , 2020, JAMA.

[27]  S. Hegde,et al.  The important role of serology for COVID-19 control , 2020, The Lancet Infectious Diseases.

[28]  J. Desenclos,et al.  Cluster of coronavirus disease 2019 (Covid-19) in the French Alps, 2020 , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[29]  J. Duchin,et al.  Detection of SARS-CoV-2 Among Residents and Staff Members of an Independent and Assisted Living Community for Older Adults — Seattle, Washington, 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[30]  Gang Wu,et al.  Household transmission of SARS-CoV-2 , 2020, Journal of Infection.

[31]  C. Eloit,et al.  Sudden and Complete Olfactory Loss Function as a Possible Symptom of COVID-19. , 2020, JAMA otolaryngology-- head & neck surgery.

[32]  M. Day Covid-19: four fifths of cases are asymptomatic, China figures indicate , 2020, BMJ.

[33]  A. H. Y. Ma,et al.  In-flight transmission cluster of COVID-19: a retrospective case series , 2020, medRxiv.

[34]  G. Joynt,et al.  Understanding COVID-19: what does viral RNA load really mean? , 2020, The Lancet Infectious Diseases.

[35]  L. Luo,et al.  Modes of contact and risk of transmission in COVID-19 among close contacts , 2020, medRxiv.

[36]  Xin Zhou,et al.  Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China , 2020, The Journal of Emergency Medicine.

[37]  Yan Bai,et al.  Presumed Asymptomatic Carrier Transmission of COVID-19. , 2020, JAMA.

[38]  Jing Liu,et al.  Asymptomatic cases in a family cluster with SARS-CoV-2 infection , 2020, The Lancet Infectious Diseases.

[39]  S. Lo,et al.  A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster , 2020, The Lancet.

[40]  Jelle J Goeman,et al.  Plea for routinely presenting prediction intervals in meta-analysis , 2016, BMJ Open.

[41]  Benjamin J Cowling,et al.  Review Article: The Fraction of Influenza Virus Infections That Are Asymptomatic A Systematic Review and Meta-analysis , 2015, Epidemiology.

[42]  M. Aerts,et al.  Metaprop: a Stata command to perform meta-analysis of binomial data , 2014, Archives of Public Health.

[43]  Z. Munn,et al.  The development of a critical appraisal tool for use in systematic reviews addressing questions of prevalence. , 2014, International journal of health policy and management.

[44]  Janneke Harting,et al.  Development of a theory- and evidence-based intervention to enhance implementation of physical therapy guidelines for the management of low back pain , 2014, Archives of Public Health.

[45]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement , 2009, BMJ.

[46]  L. Mermel,et al.  Does Influenza Transmission Occur from Asymptomatic Infection or Prior to Symptom Onset? , 2009, Public health reports.

[47]  D. Levy-bruhl,et al.  Cluster of Coronavirus Disease 2019 (COVID-19) in the French Alps, February 2020 , 2020 .

[48]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2009, Journal of clinical epidemiology.